- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT03112239
Chronic Effects Using Light-Emitting Diode Therapy (LEDT) During a Resistance Exercise Protocol for Asthmatic Patients
Chronic Effects Using Light-Emitting Diode Therapy (LEDT) During a Resistance Exercise Protocol for Moderate to Severe Asthmatic Patients: a Randomized Controlled Clinical Trial.
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
This research project will be prospective, analytical and of the randomized controlled clinical trial type, with blind evaluator. The sample type will be consecutive from Santa Casa de Misericórdia de São Paulo. We will study 30 adults of both sexes with moderate to severe asthma between the ages of 20 and 70, based on the sample calculation of the outcomes of this study.
Adult individuals 20 years of age or older with a diagnosis of moderate to severe asthma of both sexes, attended at the Ambulatory of Difficult Asthma Control of Santa Casa de Misericórdia de São Paulo.
Exclusion terms include subjects diagnosed as having heart disease associated with pulmonary disease, musculoskeletal pathology that may interfere with assessment or exercise, pulmonary hypertension, calcium absorption deficiency, BMI ≥ 30 or difficulty learning.
The subjects will initially be pre-evaluated by performing pulmonary function tests, peripheral muscle strength (1-RM), functional capacity tests, physical activity questionnaires and clinical control of asthma and cardiopulmonary exercise test. After the evaluation, patients will be randomized into two resistance training groups, one of them associated with active LED phototherapy and another LED phototherapy placebo.
The resistance exercise protocol will be performed on the muscles: Pectoral, Large Dorsal, Brachial Biceps, Brachial Triceps, Quadriceps and Tibial Ischia. The intensity will be from 40 to 70% obtained in the 1-RM test with two to three sets of ten repetitions.
The load increase will be performed weekly (5%) according to patient tolerance. After 12 weeks all subjects were reevaluated and the last reevaluation occurred at the end of the training program. Patients will only effectively begin participating in this study after explaining the terms of the survey and by accepting written consent from the ICF.
The mean (in kg) of the resistance training protocol for lower limbs in knee extension of group 1 was 33 ± 13 kg and the mean of group 2 was 46 ± 11 kg. The sample calculation was based on the load of the quadriceps muscle, α = 0.05 and β = 95%, determining a minimum of fourteen individuals for each group. An additional 10% was added to compensate for possible losses during the protocol. Thus a minimum of fifteen individuals will be required for the study.
Linear regression models will be used to evaluate the effect of the LED on the results (absolute change and percentage) and a sensitivity analysis with the values of the results in the revaluation, adjusted by the initial value of each result. The possible correlations between the variables can be evaluated using Pearson's correlation. The level of significance adopted will be p <0.5. The analyzes were performed with SPSS 20 software.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
São Paulo, Brasilia, 05415-012
- Ivan Peres Costa
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Patients with a medical outpatient setting less than six months; With a stable clinical picture during three months, ie without exacerbations and with optimized drug therapy.
Signed an informed consent form (TCLE) accepting participation in the research.
Exclusion Criteria:
- Diagnosis of heart disease associated with lung disease, musculoskeletal disease that may interfere with assessment or exercise, pulmonary hypertension, calcium absorption deficiency, BMI ≥ 30, or difficulty learning.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kaksinkertainen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: photobiomodulation by active LEDT
The subjects will be initially pre-evaluated by performing pulmonary function tests, peripheral muscle strength tests, functional capacity tests, physical activity questionnaires and clinical control of asthma, and cardiopulmonary exercise test.
After the evaluation, patients will be randomized into two resistance training groups, one of them being associated to the intervention with active photobiomodulation by LEDT to increase peripheral muscle function post resistance training.
|
Light-emitting diode, has effects similar to the photobiomodulation by low-level laser intensity.
Muut nimet:
|
|
Placebo Comparator: photobiomodulation by Placebo LEDT
The subjects will be initially pre-evaluated by performing pulmonary function tests, peripheral muscle strength tests, functional capacity tests, physical activity questionnaires and clinical control of asthma, and cardiopulmonary exercise test.
After the evaluation, patients will be randomized into two resistance training groups, one of them being associated to the intervention with placebo LEDT photobiomodulation to increase peripheral muscle function post resistance training.
|
Light-emitting diode, has effects similar to the photobiomodulation by low-level laser intensity.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Pectoral Muscular Strength by 1RM.
Aikaikkuna: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the pectoral muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Major Dorsal Muscular Strength by 1RM
Aikaikkuna: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the major dorsal muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Femoral Quadriceps Muscular Strength by 1RM
Aikaikkuna: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the femoral quadriceps muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Brachial Triceps Muscular Strength by 1RM
Aikaikkuna: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the brachial triceps muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Brachial Biceps Muscular Strength by 1RM
Aikaikkuna: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the brachial biceps muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Tibial Ischia Muscular Strength by 1RM
Aikaikkuna: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the tibial ischia muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Functional Capacity by Cardiopulmonary exercise test.
Aikaikkuna: Change from baseline measured by cardiopulmonary exercise test up to 24 weeks.
|
The cardiopulmonary test will be performed in an electricomagnetic braking cycle ergometer connected to a system composed of gas analysis module attached to a module flow/wave analyzer and a microcomputer BreezeCardiO2 System.
(medical Graphics Corporation - MGC, St. Paul, Mo, USA).
|
Change from baseline measured by cardiopulmonary exercise test up to 24 weeks.
|
|
Functional Capacity by Incremental Shuytle Walk Test.
Aikaikkuna: Change from baseline measured by Incremental Shuttle Walk Test distance up to 24 weeks.
|
The incremental shuttle walk test was performed based on the original test description.
The patient walk from side to side in a space of 10 meters identified by two cones inserted 0.5 from each end to avoid such sudden changes in speed.
The participant was instructed to walk from cone to cone in one.
A single point that the participant must keep pace and a triple beep indicates the beginning of a new level, the height at which the participant has increased the pace.
The test comprised 12 levels, each lasting one minute.
The speed of the first level was 1.8 Km/h, with an increase of 0.17 m/s every minute until reaching a top speed of 8.53 Km/h.
The test was stopped when the participant was unable to reach the cone before the next beep.
|
Change from baseline measured by Incremental Shuttle Walk Test distance up to 24 weeks.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Opintojohtaja: Luciana MM Sampaio, PhD, University of Nove de Julho
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Miranda EF, Leal-Junior EC, Marchetti PH, Dal Corso S. Acute effects of light emitting diodes therapy (LEDT) in muscle function during isometric exercise in patients with chronic obstructive pulmonary disease: preliminary results of a randomized controlled trial. Lasers Med Sci. 2014 Jan;29(1):359-65. doi: 10.1007/s10103-013-1359-5. Epub 2013 Jun 7.
- Dourado VZ, Tanni SE, Antunes LC, Paiva SA, Campana AO, Renno AC, Godoy I. Effect of three exercise programs on patients with chronic obstructive pulmonary disease. Braz J Med Biol Res. 2009 Mar;42(3):263-71. doi: 10.1590/s0100-879x2009000300007.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- ERAMG-LED-PL-01
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Yhdysvalloissa valmistettu ja sieltä viety tuote
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Vastusharjoittelu
-
King Saud Medical CityAktiivinen, ei rekrytointiHigh Fidelity Simulation Training | LeikkaussalitSaudi-Arabia
-
Inland Norway University of Applied SciencesValmisHeat-suit Endurance Training | Ei-lämpöpukukestävyysharjoitteluNorja
-
National University Hospital, SingaporeValmis
-
The University of Hong KongRekrytointiHigh Fidelity Simulation TrainingHong Kong
-
Methodist Health SystemValmisMock Code Training SimulationYhdysvallat
-
Selcuk UniversityValmisHight Intensity Interval TrainingTurkki (Türkiye)
-
The University of Texas Medical Branch, GalvestonValmisHigh Fidelity Simulation TrainingYhdysvallat
-
Drexel UniversityValmisInhibitory Control Training | GameifactionYhdysvallat
-
University of ThessalyValmisOhjaus | Speed Endurance Training Protocol 1 | Speed Endurance Training Protocol 2Kreikka
-
Medical University of SilesiaValmisStressi, fysiologinen | High Fidelity Simulation TrainingPuola
Kliiniset tutkimukset Light-Emitting Diode Therapy (LEDT)
-
University of Nove de JulhoRekrytointiDiabetes mellitus, tyyppi 2 | Harjoituskoulutus | Korkean intensiteetin intervalliharjoittelu | Tyypin 2 diabeteksesta johtuva hyperglykemiaBrasilia
-
University of Sao PauloValmis
-
Boston VA Research Institute, Inc.VA Boston Healthcare System; Vielight Inc.RekrytointiKognitiivinen toimintahäiriö | Traumaattinen aivovamma | Suljettu päävammaYhdysvallat
-
University of Sao PauloTuntematon
-
Massachusetts General HospitalNational Cancer Institute (NCI); Jawaharlal Nehru Medical CollegeValmis
-
Zealand University HospitalGöteborg University; University of Copenhagen; Technical University of Denmark ja muut yhteistyökumppanitRekrytointi
-
Zealand University HospitalUniversity of Copenhagen; Technical University of Denmark; OptoCeuticsValmis
-
University of Sao PauloTuntematonDiabetes mellitus | HaavaBrasilia
-
Antonio Francesco UrbinoScuola Superiore di Osteopatia ItalianaTuntematonPäänsärkyhäiriöt | Ensisijainen päänsärkyhäiriöItalia
-
Charite University, Berlin, GermanyRekrytointi